Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis

Media type: E-Article
Title: Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma : a cost-effectiveness analysis
Contributor: Burian, Egon [Author]; Palla, Benjamin [Author]; Callahan, Nicholas [Author]; Pyka, Thomas [Author]; Wolff, Constantin [Author]; von Schacky, Claudio E. [Author]; Schmid, Annabelle [Author]; Froelich, Matthias F. [Author]; Rübenthaler, Johannes [Author]; Makowski, Marcus R. [Author]; Gassert, Felix [Author]
Published: 24 May 2022
Published in: European journal of nuclear medicine and molecular imaging ; 49(2022), 11 vom: Sept., Seite 3870-3877
Language: English
DOI: 10.1007/s00259-022-05843-4
Identifier:

Keywords: Cost effectiveness analysis ; CT ; Head and neck cancer ; MRI ; Oncology ; PET/CT
Origination:
Footnote:
Description: Treatment of oral squamous cell carcinoma (OSCC) is based on clinical exam, biopsy, and a precise imaging-based TNM-evaluation. A high sensitivity and specificity for magnetic resonance imaging (MRI) and F-18 FDG PET/CT are reported for N-staging. Nevertheless, staging of oral squamous cell carcinoma is most often based on computed tomography (CT) scans. This study aims to evaluate cost-effectiveness of MRI and PET/CT compared to standard of care imaging in initial staging of OSCC within the US Healthcare System.
Access State: Open Access

Search in field: